BEAM

Beam Therapeutics Inc. NMS · BEAM

$26.75 -0.54 (-1.98%)

Pullback · -1.84σ

+ Compare Open in Sniper

Valuation

Market cap $2.8B

P/E (ttm) —

Forward P/E -5.6

Beta (5y) 2.18

Shares out 102.9M

Div yield —

Profitability & returns

ROE -5.8%

Net margin -40.2%

FCF margin -142.4%

Debt / equity 0.22

Trading information

Last price $26.75

Day range $26.61 – $27.17

52-wk range $21.63 – $38.26

Avg volume 2.4M

RSI (2) 29.8

Trend zone Pullback

52-week range · today's price

$21.63$38.26

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-04

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparti…